Skip to main content

Irene Montllor Ramoneda

Institutions of which they are part

Cardiovascular Diseases
Vall Hebron Institut de Recerca

Irene Montllor Ramoneda

Institutions of which they are part

Cardiovascular Diseases
Vall Hebron Institut de Recerca

Projects

Rehab+

IP: Jordi Lozano Torres
Collaborators: Irene Montllor Ramoneda
Funding agency: EIT- European Institute of Innovation & Technolog
Funding: 55865.85
Reference: REHAB+_EIT HEALTH2020
Duration: 01/01/2021 - 31/12/2022

Preventing cardiovascular ischemic events and arresting their consequences in type 2 diabetic population: a multidisciplinary clinical and experimental approach

IP: -
Collaborators: Ignacio Ferreira González, José Antonio Barrabés Riu, Alejandro Bustamante Rangel, Joan Montaner Villalonga, Immaculada Raurell Saborit, Joan López Hellin, Antonio González Fernández, Antonia Sambola Ayala, Marta García Ramírez, Joaquin Lopez Soriano, Anna Meseguer Navarro, Antonio Rodríguez Sinovas, Artur Evangelista Masip, Rafael Simó Canonge, Santiago Aguade Bruix, Francesc Moreso Mateos, Cristina Hernández Pascual, Anna Penalba Morenilla, Maria Martell Pérez-Alcalde, Neus Bellera Gotarda, Natalia Ramos Terrades, Andreea Ciudin Mihai, Maria Mar Hernandez Guillamon, Yolanda Riba Llena, Meritxell Ibernon Vilaró, Ignasi Barba Vert, Jordi Bañeras Rius, Bruno García del Blanco, Daniel Serón Micas, María Eugenia Espinel Garuz, Marisol Ruiz Meana, Maria Pilar Delgado Martínez, Irene Montllor Ramoneda, Irina Betsabe Torres Rodriguez, Javier Inserte Igual, Anna Rosell Novel, Olga Simó Servat, Joan Genescà Ferrer, Mònica Pons Delgado, M Antonieta Azancot Rivero, Maria Nazarena Pizzi , M Antonieta Azancot Rivero
Funding agency: Instituto de Salud Carlos III
Funding: 825000
Reference: PIE13/00027
Duration: 01/01/2014 - 30/06/2018

Related news

A study, in which Vall d'Hebron has participated, has analysed all the interventions of this type carried out between 2006 and 2020.

The project evaluates the feasibility of implementing LOLA, an AI-based virtual medical assistant with conversational technology that provides personalized tracking to patients suffering from heart failure.

La recerca és fonamental per contrarestar els efectes de la pol·lució, que segons l’AEMPS, va ser la causa de més de 300.000 morts prematures a la UE el 2020.

Related professionals

Montserrat García Portabella

Montserrat García Portabella

Reconstructive Surgery of the Locomotor System
Read more
Tianlu Li

Tianlu Li

Read more
Kevin Ricardo Arias Alpizar

Kevin Ricardo Arias Alpizar

Read more
Maria Clemente Leon

Maria Clemente Leon

Growth and Development
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.